Literature DB >> 22278763

Topical beta-blocker treatment for migraine.

Patrick J T Chiam1.   

Abstract

Beta-blockers are a well-known prophylactic treatment for migraine; however, treatment by the ocular route has not been widely considered. This case illustrates the resolution of a visual field defect associated with migraine and improvement of symptoms possibly due to administration of a topical beta-blocker. This novel method of treatment especially when visual field defects are present may have a place in the management of migraine.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22278763     DOI： 10.1007/s10792-012-9516-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN： 0165-5701            Impact factor:   2.031


  7 in total

1.  Topical timolol prevented migraine attacks.

Authors:  J Bhagey; B James
Journal:  Eye (Lond)       Date:  2004-07       Impact factor: 3.775

2.  Complicated migraine. A study of permanent neurological and visual defects caused by migraine.

Authors:  R C CONNOR
Journal:  Lancet       Date:  1962-11-24       Impact factor: 79.321

3.  Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of beta-blockers.

Authors:  R L Gross; S H Hensley; F Gao; S M Wu
Journal:  Surv Ophthalmol       Date:  1999-06       Impact factor: 6.048

4.  Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily.

Authors:  A H Shedden; J Laurence; A Barrish; T V Olah
Journal:  Doc Ophthalmol       Date:  2001-07       Impact factor: 2.379

5.  Visual field losses in subjects with migraine headaches.

Authors:  A M McKendrick; A J Vingrys; D R Badcock; J T Heywood
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

6.  A Pediatric Case of Ophthalmoplegic Migraine with Recurrent Oculomotor Nerve Palsy.

Authors: 
Journal:  Jpn J Ophthalmol       Date:  2000-09-01       Impact factor: 2.447

7.  Glaucomatous visual field defects in patients with migraine.

Authors:  Selçuk Comoğlu; Alper Yarangümeli; Ozlem Gürbüz Köz; Atilla Halil Elhan; Gülcan Kural
Journal:  J Neurol       Date:  2003-02       Impact factor: 4.849
  7 in total
  4 in total

1.  Timolol Eyedrops in the Treatment of Acute Migraine Attacks: A Randomized Crossover Study.

Authors:  Matthew Cossack; Edward Nabrinsky; Heath Turner; Ashley Abraham; Sean Gratton
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

Review 2.  Beta blocker eye drops for treatment of acute migraine.

Authors:  Carl V Migliazzo; John C Hagan
Journal:  Mo Med       Date:  2014 Jul-Aug

3.  Role of endothelial cells in antihyperalgesia induced by a triptan and β-blocker.

Authors:  E K Joseph; J D Levine
Journal:  Neuroscience       Date:  2012-12-20       Impact factor: 3.590

4.  A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.

Authors:  Dipika Aggarwal; Andrew J Heim; Brennen Bittel; Deetra Ford; Richard Dubinsky; Gary Gronseth; Vernita Hairston; Patrick Landazuri; Fred Sachen; Laura Herbelin; Richard J Barohn
Journal:  Kans J Med       Date:  2020-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.